Benzodiazepine-Refractory Status Epilepticus - Which Drug is Second-Line?

December 27, 2019 00:23:35
Benzodiazepine-Refractory Status Epilepticus - Which Drug is Second-Line?
Critical Care Perspectives in Emergency Medicine
Benzodiazepine-Refractory Status Epilepticus - Which Drug is Second-Line?

Dec 27 2019 | 00:23:35

/

Show Notes

Up to one-third of patients with status epilepticus will not respond to benzodiazepines.  Unfortunately, treatment of benzodiazepine-refractory status epilepticus is not well studied.  The longer seizures persist, the worse patients do.  In this podcast, we discuss the results of the recently completed ESETT trial that evaluated three anticonvulsant medications for status epilepticus.

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode 0

March 19, 2019 00:18:13
Episode Cover

BMV for ETI in the Critically Ill?

More than 1.5 million patients undergo endotracheal intubation each year in the U.S.  Endotracheal intubation can be complicated by hypoxemia, which is a known...

Listen

Episode 0

April 13, 2017 00:22:44
Episode Cover

Top 10 Pearls for the Critically Ill Elderly Patient

The number of critically ill elderly patients continues to increase annually.  In this podcast, we discuss key pearls and pitfalls in resuscitating the sick...

Listen

Episode 0

June 19, 2017 00:17:50
Episode Cover

Angiotensin II for Vasodilatory Shock?

This month Mike McCurdy rejoins the podcast to discuss the ATHOS-3 trial.  Mike was one of the co-authors on this impressive publication and gives...

Listen